Understanding OUR Cytokine-Based Immunotherapy Candidates Our dedication extends to advancing a robust portfolio of programs aimed toward increasing the horizons of cytokine-based immunotherapy, especially for cancers where therapy alternatives remain limited. Use the links below to learn additional about our portfolio of cytokine-based immunotherapy candidates. Take a look at https://financefeeds.com/sec-whistleblower-program-could-regain-protections-stripped-by-us-supreme-court/